Cabot (NYSE:CBT) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Cabot (NYSE:CBT) announced its quarterly earnings results on Monday. The specialty chemicals company reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.06, FiscalAI reports. The business had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $927.29 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter last year, the firm earned $1.70 EPS.

Cabot Price Performance

Shares of NYSE CBT opened at $75.64 on Tuesday. The company has a market capitalization of $3.90 billion, a PE ratio of 21.31, a PEG ratio of 8.68 and a beta of 0.83. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The stock’s 50 day moving average price is $77.79 and its 200-day moving average price is $79.52. Cabot has a twelve month low of $58.33 and a twelve month high of $94.53.

Insider Buying and Selling

In related news, CEO Sean Keohane sold 134,895 shares of Cabot stock in a transaction on Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the sale, the chief executive officer directly owned 404,134 shares in the company, valued at approximately $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders sold 229,597 shares of company stock worth $19,646,746 in the last 90 days. Company insiders own 3.08% of the company’s stock.

Key Cabot News

Here are the key news stories impacting Cabot this week:

• Positive Sentiment: Cabot reported fourth-quarter adjusted EPS of $1.61, above the $1.55 consensus estimate, while revenue increased 12.2% year over year to $1.01 billion, exceeding expectations by roughly $82.7 million. Cabot Beats Q4 Earnings and Revenue Estimates
• Positive Sentiment: The company secured a $50 million U.S. Department of Energy grant to expand domestic production of advanced battery conductive additives in Louisiana and Texas. Battery Materials generated $43 million of fiscal-year EBITDA, supporting the long-term growth narrative. Cabot Fiscal 2026 Results
• Positive Sentiment: Fiscal 2026 operating cash flow of $421 million funded $207 million of capital investments, $97 million of dividends and $146 million of share repurchases, indicating solid cash generation and shareholder returns. Cabot Fiscal 2026 Results
• Neutral Sentiment: Reported fourth-quarter diluted EPS was $1.25, while adjusted EPS was $1.61 after certain items. Fiscal-year adjusted EPS totaled $6.42, compared with $7.25 a year earlier, highlighting the difference between headline earnings and underlying performance. Cabot Fourth-Quarter and Full-Year Results
• Negative Sentiment: Cabot guided to fiscal 2027 EPS of $6.15-$6.75, below the $7.03 analyst consensus. The outlook suggests investors may need to lower earnings expectations and reflects concern about weaker margins and a challenging macroeconomic environment.
• Negative Sentiment: Although quarterly adjusted EPS beat estimates, it declined from $1.70 in the prior-year quarter. The combination of lower year-over-year profitability and cautious guidance is outweighing the revenue beat. Cabot Falls Despite Beating Estimates on Weaker Margins

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. JPMorgan Chase & Co. raised their target price on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. Truist Financial set a $100.00 price target on Cabot in a research report on Wednesday, August 5th. UBS Group dropped their price objective on Cabot from $92.00 to $86.00 and set a “neutral” rating on the stock in a research note on Monday, October 5th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Cabot has a consensus rating of “Hold” and an average price target of $87.80.

About Cabot

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.